Search results

https://www.mhm.lu.se/internt/reception-eng/technical-equipment-and-instruments/borrowing-instruments-and-technical-equipment - 2026-05-23

Bilaga 1 Verksamhetsberättelse 2017 för EDS Nordic User Group Vid EDS Nordic User Groups årsmöte 2017-03-22 i Luleå valdes följande styrelsemedlemmar: ordförande Cilla Öhnfeldt, Stockholms universitet (omval), Per Falk, Högskolan i Gävle (nyval), Ann- Christin Persson, Lunds universitet (nyval), Tove Andersson, Region Skåne (nyval), Mikael Arvidsson, Karlstads universitet (omval) och Eva Sejmyr, L

https://www.ub.lu.se/sites/ub.lu.se/files/verksamhetsberattelse_2017_for_eds_nordic_user_group.pdf - 2026-05-25

Primary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disorder associated with autosomal recessive variants in genes required for perforin-mediated lymphocyte cytotoxicity. A rapid diagnosis is crucial for successful treatment. Although defective cytotoxic T lymphocyte (CTL) function causes pathogenesis, quantification of natural killer (NK)–cell exocytosis triggered by K562 targe

Streptococcus pyogenes (Group A streptococcus; GAS) is an important human pathogen responsible for mild to severe, life-threatening infections. GAS expresses a wide range of virulence factors, including the M family proteins. The M proteins allow the bacteria to evade parts of the human immune defenses by triggering the formation of a dense coat of plasma proteins surrounding the bacteria, includi

Recent epidemiological data on diseases caused by beta-hemolytic streptococci belonging to Lancefield group C and G ( GCS, GGS) underline that they are an emerging threat to human health. Among various virulence factors expressed by GCS and GGS isolates from human infections, M and M-like proteins are considered important because of their anti-phagocytic activity. In addition, protein G has been i

Background: Ocrelizumab is a humanized anti-CD20 antibody with increased antibody-dependent cellular cytotoxicity compared with rituximab. This phase I/II study evaluated its safety and efficacy in patients with relapsed/refractory follicular lymphoma (FL) after prior rituximab therapy. Design and methods: Forty-seven patients were treated in three dose cohorts and received eight infusions every 3

Streptococcus pyogenes is one of the most common bacteria infecting humans. One of the factors contributing to the disease-causing properties is the secreted streptococcal cysteine proteinase, SpeB, which degrades several host proteins in connective tissue and circulation. SpeB activity depends on the transformation from an inactive precursor, zymogen, into a mature proteinase. We show that

This study explores the use of manganese ore, iron-carbon particles (Fe-C), and gravel as anode fillers in electroactive constructed wetlands (ECWs) to treat wastewater containing pharmaceuticals and personal care products (PPCPs) including ciprofloxacin (CIP), ofloxacin (OFL), and naproxen (NPX), while also assessing bioelectricity production. Although the presence of PPCPs reduced pollutant remo

INTRODUCTION: Synaptic dysfunction and loss are pathological hallmarks of neurodegenerative diseases. Neuronal pentraxin 2 (NPTX2), a presynaptic protein involved in synaptic plasticity, has been linked to cognitive decline in Alzheimer's disease (AD) and other neurodegenerative disorders. METHODS: We developed and validated a novel single molecule array (Simoa) for NPTX2 in cerebrospinal fluid, w

Anna-Greta Crafoords pris för bästa avhandling vid Medicinska fakulteten, Lunds universitet 2025, tilldelas Arman Izadi. Han belönas för sitt avhandlingsarbete i vilket han utvecklat recept för nya effektivare antikroppar mot infektioner. Priset delas ut av Läkaresällskapet i Lund och Arman Izadi mottar priset vid sällskapets vårmöte torsdagen den 9 april 2026 kl. 18:00 på Locus Medicus, Lund, då

https://www.medicin.lu.se/artikel/recept-pa-framtidens-antikroppar-belonas - 2026-05-24

Användardagarna 15-16 april 2021 OBS! Programmet kan komma att ändras pga. oförutsedda händelser. Torsdagen den 15 april (representanter från EBSCO deltar) 13:00-13:05 Välkomna! Instruktioner kring dagen 13:05-13:35 EDS nya gränssnitt (Adam Walsh, Manager LSE) 13:35-13:55 Exempel på möjliga förändringar i EDS (Alma Taawo, Library Service Engineer) 13:55-14:05 Paus 14:05-14:25 Break out rooms sessi

https://www.ub.lu.se/sites/ub.lu.se/files/2021-05/Program%20Anv%C3%A4ndardagarna%202021-04-15--16.pdf - 2026-05-24

Välkomna till användardagarna för EBSCO Systems Nordic User Group! Tid: 18 mars kl 13-17 och 19 mars kl 9.30-14.30 Plats: Zoom (länkar, en för onsdagen och en för torsdagen, skickas ut till alla som har anmält sig här) Onsdagen den 18 mars 13.00-13.15 Välkommen och presentation 13.15-14.00 Nyheter från EBSCO: nya funktioner och nya tjänster – Richard Burkitt, EBSCO 14.00-14.30 Presentation av komm

https://www.ub.lu.se/sites/ub.lu.se/files/program_esnug_anvandardagar_18-19_mars_2020.pdf - 2026-05-25